The U.S. Food and Drug Administration (FDA) recently took steps to streamline its operations, which is designed to give the agency a methodology for quicker response to regulatory action about a food or drug and could become a major benefit for their future work in cannabis. In 2014, The Program Alignment Group, made up of […]